Lihong Zhang, MD, PhD

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, China (People's Republic)

Poster(s):

• (P 409) PHASE 2 STUDY EVALUATING SURUFATINIB IN PATIENTS WITH OSTEOSARCOMA AND SOFT TISSUE SARCOMA WHO HAVE FAILED STANDARD CHEMOTHERAPY